Highlights from a webinar hosted by Scientist.com.
attain best practice for successfully navigating the value, access, and evidence process
insights into the relevance and timing of a range of market access projects within biotechnology
obtain recommendations for assessing market access risks and opportunities based on pricing potential and evolving payer needs.
Moderated by Dr Patti Peeples, President of HealthEconomics.com.
Steven has more than 15 years’ experience in sales, marketing, and market access roles in both consultancy and industry and has worked directly with payers and providers to facilitate market access of pharmaceutical products.
He has a deep understanding of HTA/P&R processes and evidence requirements in major markets and has worked in numerous therapy areas, including oncology, hematology, gastroenterology, rheumatology, endocrinology, and rare diseases.
Duration: 20 minutes.
The discussion is essential viewing for biotechnology manufacturers that want to deliver faster patient access to innovative therapies.
“Thanks for the webinar. It was interesting to explore the case studies in depth and I found it useful to confirm our perspectives.”
Global Pricing and Reimbursement Director, leading pharmaceutical company
“Very clear and concise presentation, thank you.”
VP Market Access and Reimbursement, emerging biotech
“Very informative session. The points covered are making me re-think the scope of possible work I’m considering.”
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.